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Abstract 
Background: To enhance indicated prevention in patients with a clinical high risk (CHR) 
for psychosis, recent research efforts have been increasingly directed towards estimating 
the risk of developing psychosis on an individual level using multivariable clinical 
prediction models. The aim of this study was to systematically review the methodological 
quality and reporting of studies developing or validating such models. 
Methods: A systematic literature search was carried out (up to March 14, 2016) to find all 
studies that developed or validated a clinical prediction model predicting the transition to 
psychosis in CHR patients. Data were extracted using a comprehensive item list which 
was based on current methodological recommendations. 
Results: Ninety-one studies met the inclusion criteria. None of the retrieved studies 
performed a true external validation of an existing model. Only three studies (3.5%) had 
an event per variable ratio of at least 10, which is the recommended minimum to avoid 
overfitting. Internal validation was performed in only 14 studies (15%) and seven of these 
used biased internal validation strategies. Other frequently observed modelling 
approaches not recommended by methodologists included univariable screening of 
candidate predictors, stepwise variable selection, categorization of continuous variables, 
and poor handling and reporting of missing data. 
Conclusions: Our systematic review revealed that poor methods and reporting are 
widespread in prediction of psychosis research. Since most studies relied on small 
sample sizes, did not perform internal or external cross-validation, and used poor model 
development strategies, most published models are likely overfitted and their reported 
predictive accuracy is likely overoptimistic. 
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Introduction 
The early detection and treatment of psychoses already in their prodromal stage have 
become widely accepted goals in psychiatry during the last two decades (Fusar-Poli et 
al., 2013b). Consequently, a number of operational criteria aiming at identifying patients 
with a clinical high risk (CHR) for psychosis have been established internationally. 
However, meta-analyses suggest that - among help-seeking individuals - about one third 
of those meeting internationally established CHR criteria will develop psychosis within 
five years (Fusar-Poli et al., 2012, Schultze-Lutter et al., 2015) with about 73% of these 
developing schizophrenic psychoses (Fusar-Poli et al., 2013a) and about one third is 
having a clinical remission within two years (Simon et al., 2013). Hence, risk stratification 
of CHR patients offers great potential for enhancing clinical decision making and 
improving the cost-benefit ratio of preventive interventions (Ruhrmann et al., 2012). 
Accordingly, recent research efforts have been increasingly directed toward estimating 
the risk of developing psychosis on an individual level. The trend towards indicated 
prevention and personalized medicine in early stages of psychosis is exemplified by the 
fact that several large multicenter studies (i.e. PRONIA, PSYSCAN and NAPLS III) are 
currently underway aiming at developing prognostic tools in CHR patients. Furthermore, 
an ever-increasing number of studies are seeking to improve the prediction of psychosis 
in CHR patients by incorporating single risk factors and indicators into multivariable 
prediction models (e.g. Cannon et al., 2008, Riecher-Rössler et al., 2009, Ruhrmann et 
al., 2010). By using the term multivariable models we refer to models with multiple 
predictor variables (i.e. independent variables) and one outcome variable (i.e. dependent 
variable) as opposed to multivariate models, which have multiple outcome variables 
(Hidalgo and Goodman, 2013).  
However, despite considerable research efforts, no psychosis risk prediction model has 
yet been adopted in clinical practice. The most likely explanation for this is that none of 
the published models has yet been convincingly demonstrated to have sufficient validity 
and clinical utility. While a lack of progress in this area could be partly attributed to the 
fact that psychoses are complex disorders with large phenomenological, 
pathophysiological, and etiological heterogeneity (Keshavan et al., 2011) and that there 
are heterogeneous subgroups within CHR samples (Fusar-Poli et al., 2016), another 
important obstacle to consider is the widespread use of poor (i.e., biased and inefficient) 
modelling strategies, which can severely compromise the reliability and validity of the 
developed models. Examples of poor modelling strategies are relying on small event per 
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variable (EPV) ratios (i.e. small number of patients with transition to psychosis relative to 
the number of considered predictor variables), using biased methods to select predictor 
variables for inclusion into the multivariable prediction model among a set of candidate 
predictor variables, not properly assessing the predictive accuracy of the model, using 
inappropriate model types, and not efficiently dealing with missing data (D'Amico et al., 
2016, Wynants et al., 2016). Systematic reviews on the methodology of studies 
developing clinical prediction models for type 2 diabetes (Collins et al., 2011), cancer 
(Mallett et al., 2010), traumatic brain injury outcome (Mushkudiani et al., 2008), kidney 
disease (Collins et al., 2013), or medicine in general (Bouwmeester et al., 2012) all found 
that the use of such methods is widespread. Hence, it is reasonable to assume that poor 
methods are also a widespread problem in prediction of psychosis research. 
Unfortunately, a systematic review on the methodology and reporting of studies 
developing or validating models predicting psychosis in CHR patients using rigorous 
quality criteria has not yet been conducted. Although one systematic review (Strobl et al., 
2012) has focused on methods and performance of models predicting the onset of 
psychosis, several critical aspects, such EPV ratios, selection of predictor variables, 
assessment of predictive performance, and dealing with missing data, were not 
addressed. This might be because up until recently, no guidance existed to help form a 
well-defined review question and determine which details to extract and critically 
appraise from prediction modelling studies (Moons et al., 2014). Fortunately, such 
guidance has now become available with the publication of the Checklist for critical 
Appraisal and data extraction for systematic Reviews of Prediction Modelling Studies 
(CHARMS; Moons et al., 2014) which was developed by a panel of experts of the 
Cochrane Prognosis Methods Group. 
The present systematic review therefore aims to critically appraise the methodology and 
reporting of studies developing or validating models predicting psychosis in CHR 
patients. We reviewed prediction modelling studies regardless of the domains predictor 
variables were selected from. In accordance with the recently published CHARMS and 
other guidelines on clinical prediction modelling (e.g., Altman et al., 2012, Collins et al., 
2015), all important methodological issues are addressed, including effective sample 
size, type of model used, selection and transformation of variables, assessment of 
predictive performance, internal and external validation, and treatment of missing data. 
The ultimate goal of this paper is to enhance the methodology and reporting of future 
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studies not only by identifying frequent sources of bias but also by giving 
recommendations for improvement. To facilitate understanding, brief explanations of key 
statistical concepts in prognostic modelling are provided in Table 1 (see also Fusar-Poli 
and Schultze-Lutter, 2016).  
Methods 
Search strategy 
A literature search was carried out (up to March 14, 2016) in the databases of Medline, 
Embase, PsycINFO, and Web of Science using the following search terms: (predict* OR 
"vulnerability marker" OR "risk factors for transition") AND psychosis AND ("clinically at 
high risk" OR "clinically at risk" OR "clinical high risk" OR "ultra high risk" OR prodrom* 
OR "at risk mental state" OR "risk of psychosis”). The search was restricted to English 
language papers published from 1998 onwards because this marks the time when the 
first prospective studies with patients meeting validated clinical high risk criteria were 
published (Yung et al., 1998). The publication type was restricted to articles only, thus 
excluding meeting abstracts, editorials, letters, reviews and comments. In addition, the 
reference lists of the included studies were screened to identify further potentially 
relevant studies. 
Study selection 
Studies were included if they met the following criteria: (1) involved subjects with a CHR 
for psychosis that were prospectively followed up, (2) developed or validated a 
prognostic model that predicted later transition to psychosis from variables obtained at 
baseline, (3) included at least two predictor variables in the prognostic model. 
CHR for psychosis was required to be diagnosed by internationally established criteria. 
That is, subjects had to fulfill either ultra-high risk (UHR), basic symptom (BS), or 
Unspecific Prodromal Symptom (UPS) criteria (for review, see Fusar-Poli et al., 2013b). 
Studies with overlapping samples were not excluded since the focus or our review was 
on methodology and reporting and not on the predictive performance of different models 
or the predicitive potential of different predictor variables. 
Studies were selected in a two-step procedure: First, all references retrieved from the 
databases were screened based on their titles and abstracts. Next, articles that were 
found to be potentially eligible were further evaluated based on their full texts. The study 
selection was performed by the first author and randomly checked by the second author. 
Discrepancies in the final classification were discussed until consensus was reached. 
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Data extraction 
We developed a comprehensive item list based on current methodological 
recommendations for developing and reporting clinical prediction models. To this end, we 
studied the item lists of previous systematic reviews evaluating prediction research in 
other medical fields (Bouwmeester et al., 2012, Collins et al., 2011, Collins et al., 2013, 
Mallett et al., 2010, Mushkudiani et al., 2008, van Oort et al., 2012), existing reporting 
statements and checklists (i.e., the CHARMS, Transparent reporting of a multivariable 
prediction model for individual prognosis or diagnosis (TRIPOD; Collins et al., 2015), 
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK; Altman et 
al., 2012), as well as current text books (Harrell, 2001, Steyerberg, 2009) and articles 
(Altman et al., 2009, Moons et al., 2009a, Moons et al., 2009b, Royston et al., 2009, 
Steyerberg et al., 2010) on clinical prediction modeling. The first author extracted all 
data, which was randomly checked by the second author. Discrepancies were resolved 
by mutual discussions. 
 
Data analysis 
In line with a recent systematic review on clinical prediction research (Bouwmeester et 
al., 2012) we distinguished between predictor finding studies, prediction model 
development studies, and external validation studies. Predictor finding studies primarily 
aim to explore which predictors independently contribute to the prediction of the 
outcome, i.e. are associated with the outcome (Bouwmeester et al., 2012, Moons et al., 
2009b). By contrast, model development studies aim to develop multivariable prediction 
models for clinical practice (i.e. for informed decision making) that predict the outcome as 
accurately as possible. While both types of studies make use of multivariable prediction 
models, the focus of the first is more on causal explanation and hypothesis testing 
whereas the latter is more concerned with accurate prediction. Although there are clear 
similarities in the design and analysis of etiological and prognostic studies, there are 
several aspects in which they differ. For example, calibration and discrimination are 
highly relevant to prognostic research but meaningless in etiological research (Moons et 
al., 2009b). Furthermore, establishing unbiased estimates of each individual predictor 
with the outcome is important in etiological research but not in prognostic research (for 
more details on the difference between prognostic and etiological research, see Moons 
et al., 2009b, Seel et al., 2012).  
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Studies were categorized as predictor model development studies if it was clearly stated 
in the manuscript that the aim was developing a model for clinical practice and not 
merely testing the predictive potential of certain predictor variables or domains. Studies 
were categorized as external validation studies if their aim was to assess the 
performance of a previously reported prediction model using new participant data that 
were not used in the development process. All other studies fulfilling inclusion criteria 
were termed predictor finding studies.   
Since it would have been unfair to evaluate the different study types by exactly the same 
criteria, we grouped results by study type whenever necessary. Each extracted item was 
summarized in terms of absolute and relative frequencies and the results are reported 
according to the PRISMA guidelines (Moher et al., 2009).  
 
Results 
Literature search results 
The literature search identified 91 articles eligible for full review (see Figure 1). The 
included studies were published between November 2002 and February 2016. The 
number of studies published per year was increasing, with only a single study published 
in 2002 and 14 studies published in 2015. Three journals accounted for almost half of the 
publications: 28 articles (31%) appeared in Schizophrenia Research, 9 (10%) in 
Schizophrenia Bulletin and 8 (9%) in Biological Psychiatry. The full list of included 
studies is presented in Supplementary Table S1. 
Study aims 
Only 7 studies(Cannon et al., 2008, Chan et al., 2015, Michel et al., 2014, Nieman et al., 
2014, Perkins et al., 2015a, Perkins et al., 2015b, Ruhrmann et al., 2010) (8%) aimed at 
developing a clinical prediction model for application in clinical practice and thus were 
categorized as model development studies. All other studies (92%) where considered 
predictor finding studies. 
We did not identify any true external validation studies. Although Mason et al. (2004) 
aimed at replicating the results of Yung et al. (2004) and Thompson et al. (2011) aimed 
at replicating the results of Cannon et al. (2008), both studies did not evaluate an exact 
published model (i.e., applied a regression formula to new data) but re-estimated 
regression coefficients of previously identified predictors. As frequently pointed out in the 
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literature (e.g., Moons et al., 2014, Royston and Altman, 2013), such studies are not 
model validation studies, but should be considered model re-development studies. 
Study designs 
All studies where cohort studies, except one (Thompson et al., 2011) which used a 
nested cohort design. Sixty six studies (73%) were single-center and 25 (28%) were 
multicenter studies. Data were collected at 27 different centers. Many studies had 
overlapping samples. For instance, more than one fourth (25.3%) of the published 
studies were based on data collected at the Personal Assessment and Crisis Evaluation 
(PACE) clinic in Melbourne, although not always from the same time periods. The used 
criteria for identifying CHR patients and assessing transition to psychosis are displayed 
in Supplementary Table 2. The length and frequency of follow-up differed markedly 
between studies. Whereas some studies assessed transition to psychosis on a monthly 
basis in the first year (e.g., Riecher-Rössler et al., 2009), others conducted follow-up 
assessments only on a yearly or less frequent basis, which poses the risk of missing at 
least some transitions and might lead to a less accurate estimation of the time to 
transition. The average follow-up duration (from the 84 studies it could be determined) 
was 33.1 months (median: 27.9 months, range: 12-90 months). 17% of these studies had 
a follow-up duration of only one year, 33% of less than 2 years, and 60% of less than 3 
years. 
Number of patients and transitions 
The average number of included CHR patients per study was 128 (SD: 134) and the 
average number of transitions was 29.8 (SD: 25.2). Although model development studies 
tended to have a higher number of included patients and transitions than predictor 
finding studies (252 vs. 118 and 56.1 vs. 27.6, respectively), these differences did not 
reach statistical significance. The average proportion of patients with later transition to 
psychosis was 27% (median: 26%, range: 5-53%). Since for a binary or a time-to-event 
outcome the effective sample size is the smaller of the two outcome frequencies (Moons 
et al., 2015), the effective sample size in the included studies almost always 
corresponded to the number of cases with later transition to psychosis and thus on 
average was only about one fourth of the number of included CHR patients. 
Number and type of considered predictor variables 
The number of considered predictor variables could be determined in 85 studies (93%) 
and was 23.7 on average (median: 12, SD: 36.9, range: 2-225). Model development 
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studies considered significantly more predictor variables than predictor finding studies 
(97 vs. 17.1 predictors, p = 0.040). The most frequently covered domains were positive 
symptoms, followed by negative symptoms, socio-demographic characteristics, and 
general, social- and occupational functioning (see Figure 2). 
Event per variable ratio 
The average number of events per considered predictor variable (EPV) was 3 (median: 
1.8, SD: 3, range: 0.1-14.3). Although model development studies tended to have 
smaller average EPV than predictor finding studies (1.8 vs. 3.1), this difference did not 
reach statistical significance. Only 3 studies (Stowkowy et al., 2016, Velthorst et al., 
2013a, Walder et al., 2013) (3.5%), all of which were predictor finding studies, had an 
EPV of at least 10.  
Missing data 
Missing data at baseline was only explicitly mentioned in 28 studies (31%). The number 
of subjects with missing data was reported in 24 studies (26%), the number of missing 
values for each predictor in 11 studies (12%), and the number of subjects lost to follow-
up in 35 studies (38%). Nine studies (10%) reported to have omitted at least one 
predictor with missing values. The vast majority of studies handled missing data by 
performing complete case analyses, although this was only made explicit in 26 studies 
(29%) and must be assumed for those studies that did not mention missing data.(Moons 
et al., 2015) Multiple imputation was only used in four studies (4%) (Nieman et al., 2014, 
Nieman et al., 2013, Rüsch et al., 2015, Seidman et al., 2010) while single imputation 
was applied in two studies (2%) (Cornblatt et al., 2015, Demjaha et al., 2012). 
Model types 
The most frequently used model types were Cox proportional hazard and logistic 
regression models, which were used in 51 (56%) and 23 (25%) studies, respectively. 
Five studies (5.5%) had fitted both of these models. A small number of studies applied 
more modern statistical learning methods, such as support vector machines 
(Koutsouleris et al., 2012a, Koutsouleris et al., 2012b, Koutsouleris et al., 2009), 
Koutsouleris et al. (2015) (4%), least absolute shrinkage and selection operator (LASSO) 
(Chan et al., 2015, Ramyead et al., 2015) (2%), greedy algorithm (Perkins et al., 2015a, 
Perkins et al., 2015b) (2%), partial least squares discriminant analysis (Huang et al., 
2007) (1%) and convex hull classification (Bedi et al., 2015) (1%). Linear discriminant 
analysis was used in one study (Mittal et al., 2010) (1%). One study (Healey et al., 2013) 
Studerus et al., 2016    
10 
 
(1%) appeared to have used an ordinary least square regression model with a binary 
outcome, which clearly violates modelling assumptions. 
Selection of predictor variables and dimensionality reduction 
Pre-selection of candidate predictors for inclusion in the multivariable analyses based on 
univariable predictor-outcome associations was performed in 32 studies (35%). Six 
studies reduced the number of predictors before inclusion to the final models by applying 
dimensionality reduction methods, such as principal component analysis (Huang et al., 
2007, Koutsouleris et al., 2012a, Koutsouleris et al., 2009, Koutsouleris et al., 2015, 
Raballo et al., 2011), exploratory factor analysis (Demjaha et al., 2012) and latent class 
factor analysis (Velthorst et al., 2013a). 
For selecting predictors within multivariable models, 34 studies (37%) used stepwise 
methods. Most of these used backward elimination methods, but six studies also used 
forward and backward stepwise, five used forward stepwise and two did not describe the 
specific stepwise method. Nine studies (10%) applied stepwise variable selections in 
multiple steps, that is, first to each of several domains, and then to the variables retained 
in each domain. The most frequently used significance threshold for stepwise variable 
selection was p = 0.05. Automated variable selection within multivariable models using 
non-stepwise-methods was conducted in only four studies. Two of these (Chan et al., 
2015, Ramyead et al., 2015) used the LASSO and two (Perkins et al., 2015a, Perkins et 
al., 2015b) a greedy algorithm. 
Transformation of predictor variables 
Three of the model development studies (Cannon et al., 2008, Perkins et al., 2015b, 
Ruhrmann et al., 2010) (43%) and 10 of the predictor finding studies (Amminger et al., 
2006, Cornblatt et al., 2015, DeVylder et al., 2014, Mason et al., 2004, Nelson et al., 
2013, O'Donoghue et al., 2015, Thompson et al., 2011, Velthorst et al., 2013b, Yung et 
al., 2003, Yung et al., 2004) (12%) fitted prediction models based on categorized or 
dichotomized continuous variables. Six of these (Cannon et al., 2008, Mason et al., 
2004, Nelson et al., 2013, Thompson et al., 2011, Yung et al., 2003, Yung et al., 2004) 
chose categorization cut-points based on the lowest p-value, one (DeVylder et al., 2014) 
based on the maximal area under the Receiver Operating Characteristic (ROC) curve 
(AUC), one (O'Donoghue et al., 2015) based on quartiles, and 5 studies (Amminger et 
al., 2006, Cannon et al., 2008, Perkins et al., 2015b, Ruhrmann et al., 2010, Velthorst et 
al., 2013b) did not provide explanations for the chosen cut-points. In at least four studies 
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(Mason et al., 2004, Nelson et al., 2013, Yung et al., 2003, Yung et al., 2004) the reason 
of dichotomizing continuous predictor variables was to provide a simple scoring rule. 
Model performance 
Table 2 displays the frequency of reporting different performance measures stratified by 
study aim. Whereas all model development studies reported at least one model 
performance measure, this was only the case in 28 (33%) of the predictor finding studies. 
If model performance was assessed, this was mainly done using classification measures, 
such as sensitivity and specificity, and less frequently using overall performance and 
discrimination measures. Calibration was not assessed in any of the model development 
studies and only in five (5%) of the predictor finding studies. Four of these (Cornblatt et 
al., 2015, Piskulic et al., 2012, Rüsch et al., 2015, Xu et al., 2016) used the Hosmer-
Lemeshow statistic and one (Perkins et al., 2015b) a calibration plot. From the 31 studies 
reporting at least one classification measure, 19 did not report the probability threshold 
for classification and whether it was chosen from the data or set a priori, three used 
model types that did not predict a probability, and eight chose the probability threshold 
from the data. From the 35 studies (38%) reporting at least one performance measure, 
21 (60%) only reported the so called apparent performance. 
Model evaluation 
Internal cross validation was carried out in only four of the model development studies 
(57%) (Michel et al., 2014, Nieman et al., 2014, Perkins et al., 2015a, Perkins et al., 
2015b) and 10 of the predictor finding studies (12%) (Bedi et al., 2015, Cornblatt et al., 
2015, Koutsouleris et al., 2012a, Koutsouleris et al., 2012b, Koutsouleris et al., 2009, 
Koutsouleris et al., 2015, Mittal et al., 2010, Ramyead et al., 2015, Riecher-Rössler et al., 
2009, Schultze-Lutter et al., 2007). Six of these (Koutsouleris et al., 2012a, Koutsouleris 
et al., 2012b, Koutsouleris et al., 2009, Koutsouleris et al., 2015, Perkins et al., 2015a, 
Ramyead et al., 2015) used k-fold cross validation, three (Cornblatt et al., 2015, Michel 
et al., 2014, Nieman et al., 2014) used bootstrapping, three (Bedi et al., 2015, Mittal et 
al., 2010, Riecher-Rössler et al., 2009) used leave-one-out-cross-validation and two 
(Perkins et al., 2015b, Schultze-Lutter et al., 2007) used a split-sampling approach. 
However, five of these studies (Cornblatt et al., 2015, Michel et al., 2014, Mittal et al., 
2010, Nieman et al., 2014, Riecher-Rössler et al., 2009) only cross-validated the final 
model and therefore did not take into account the uncertainty introduced by the variable 
selection and transformation. Only four studies (Koutsouleris et al., 2012a, Koutsouleris 
et al., 2012b, Koutsouleris et al., 2015, Ramyead et al., 2015) used nested repeated 
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cross-validation, which is considered the best approach for training and testing a 
prediction model in one sample (Krstajic et al., 2014). 
Model presentation 
Only four studies (Schultze-Lutter et al., 2012, Schultze-Lutter et al., 2007, Xu et al., 
2016, Ziermans et al., 2014) (4%) provided the full model formula, seven (8%) used 
model types that cannot be easily described with a model formula (e.g. support vector 
machine), 20 (22%) only provided p-values but not regression coefficients of predictors, 
and 60 studies (66%) only provided regression coefficients of the predictor variables but 
not the intercept or baseline survival function, which are required in logistic and Cox 
regression, respectively, to properly assess calibration (Moons et al., 2015, Royston and 
Altman, 2013). Three studies (Bang et al., 2015, Lencz et al., 2006, Riecher-Rössler et 
al., 2009) also only provided regression coefficients for standardized or otherwise 
transformed variables without giving enough details to exactly replicate the variable 
transformation in a new data set. 
Discussion 
Our systematic review identified 91 studies using a multivariable clinical prediction model 
for predicting the transition to psychosis in CHR patients. The vast majority of these 
studies (n = 84) were classified as predictor finding studies because they primarily aimed 
at hypothesis testing or evaluating the predictive potential of certain predictors or 
assessment domains. Only 7 studies stated explicitly that they aimed at developing a 
prediction model for clinical practice and therefore were classified as model development 
studies. Thus, in prediction of psychosis research, studies seem to focus much more 
often on etiology/explanation than maximizing prognostic accuracy (for a more detailed 
explanation of the difference between prognostic and etiological research, see Moons et 
al., 2009b, Seel et al., 2012). However, it should be noted that this distinction was not 
always clear-cut as many authors did not clearly describe the aim of the study or possibly 
tried to achieve both accurate prognosis and a better understanding of causal 
relationships. 
We found that poor conduct and reporting were widespread in both predictor finding and 
model developed studies and that almost all aspects of the modelling process were 
affected. The results of this review are therefore consistent with reviews of prediction 
modelling studies in other medical fields (Bouwmeester et al., 2012, Collins et al., 2011, 
Collins et al., 2013, Mallett et al., 2010, Mushkudiani et al., 2008). 
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One of the biggest concerns is that most studies relied on small effective sample sizes 
and number of events (i.e. patients with later transitions to psychosis) relative to the 
number of considered predictor variables (EPV). Small EPV ratios increase the risk of 
overfitting and overestimating the performance of the model, if it is developed and 
assessed in the same sample (Moons et al., 2015). Furthermore, it can lead to biased 
regression coefficients and unstable variable selection (Mushkudiani et al., 2008). 
Current guidelines and textbooks therefore recommend EPV ratios of at least 10 (Collins 
et al., 2015, Moons et al., 2014, Steyerberg, 2009). Unfortunately, in this review, an EPV 
of at least 10 was only achieved in three studies (Stowkowy et al., 2016, Velthorst et al., 
2013a, Walder et al., 2013) and the median EPV was only 1.8. While low EPV ratios 
have also frequently been criticized in other fields of clinical prediction research 
(Bouwmeester et al., 2012, Collins et al., 2011), the problem seems to be particularly 
severe in prediction of psychosis as reviews on studies developing models predicting 
cancer (Mallett et al., 2010), kidney disease (Collins et al., 2013), type 2 diabetes (Collins 
et al., 2011), and cardiovascular disease (Wessler et al., 2015) have reported median 
EPV ratios of 10, 29, 19, and 11-34, respectively. The much lower sample sizes in 
prediction of psychosis research can be at least partially explained by the fact that CHR 
patients are difficult to recruit and follow-up durations of at least two years are needed to 
detect most later transitions to psychosis (Kempton et al., 2015).  
However, although missing data is expected to be frequent in medical research in 
general (Sterne et al., 2009) and in early psychosis research in particular, only about one 
third of the included studies mentioned any missing data. Furthermore, reporting on the 
type and frequency of missing data was often poor. Moreover, only 4 studies (Nieman et 
al., 2014, Nieman et al., 2013, Rüsch et al., 2015, Seidman et al., 2010) (4%) performed 
multiple imputation, which is generally acknowledged as the preferred method for 
handling incomplete data (Moons et al., 2014, Sterne et al., 2009). Hence, it is likely that 
most studies had excluded subjects or variables with incomplete data, which not only 
leads to a waste of data and reduced power, but can also negatively affect the 
representativeness of the sample and consequently the generalizability of the resulting 
prediction model (Gorelick, 2006, Moons et al., 2015). Unfortunately, poor handling and 
reporting of missing data is widespread in any medical field (Bouwmeester et al., 2012). 
However, in prediction of psychosis the consequences might be particularly severe as 
samples are already quite small and a further loss of data can be less afforded. 
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Approximately 60% of both predictor finding and model development studies used Cox 
regression and thus treated the outcome as a time-to-event variable, whereas the 
remaining studies used models with a binary outcome (i.e. transition vs. non-transition). 
For prospective studies with longer-term diagnostic outcomes and regular follow-up 
assessments, as is the case in prediction of psychosis studies, time-to-event outcome 
models are more appropriate because they use more information, have more statistical 
power, and can deal with censoring (i.e. cases with incomplete follow-up) (Moons et al., 
2015, van der Net et al., 2008). Since loss to follow-up is frequent in prediction of 
psychosis research and follow-up durations often too short to capture all transitions 
(Schultze-Lutter et al., 2015), the 40% of studies that have applied a binary outcome 
model are mainly faced with two shortcomings. First, they had to exclude non-
transitioned cases with short follow-up durations, which again further aggravated the 
problem of already existing small sample sizes and might have hampered the 
representativeness of the sample. Second, patients with late transition to psychosis 
might have been misclassified as non-transitioned cases. 
Several studies (Koutsouleris et al., 2012a, Koutsouleris et al., 2012b, Koutsouleris et al., 
2009, Koutsouleris et al., 2015) used so called machine learning or pattern recognition 
methods, such as support vector machines. In line with Steyerberg et al. (2014), we 
herein use the term “machine learning method” to refer to the more modern and flexible 
statistical learning methods originally developed in the field of computer science, such as 
random forest or neural networks, which can automatically capture highly complex non-
linear relationships between predictor and response variables, and separate them from 
regression based methods traditionally used in clinical prediction modelling, such as 
logistic and Cox regression or penalized versions thereof (i.e. models in which regression 
coefficients are shrunken towards zero, such as LASSO). Since first results with machine 
learning methods have been encouraging,  a more widespread use of these methods in 
the field of early detection of psychosis is now considered by many authors a promising 
strategy to improve the prediction of psychosis (Koutsouleris and Kambeitz, 2016, 
Pettersson-Yeo et al., 2013). However, many methodologists in the field of clinical 
prediction modelling (Moons et al., 2015, Steyerberg et al., 2014) do not share this 
enthusiasm for the following reasons: First, due to their higher flexibility, machine 
learning methods are more prone to overfitting than regression based approaches, 
particularly in small data sets (van der Ploeg et al., 2014). Hence, when sample sizes are 
small, as is frequently the case in prediction of psychosis research, their performance 
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advantage resulting from the increased ability to capture the true underlying relationship 
between predictors and response might not be high enough to compensate for the 
increased tendency to overfit (Steyerberg et al., 2014). Accordingly, van der Ploeg et al. 
have shown that logistic regression outperformed support vector machines, random 
forests and neural networks in external validation, when predicting 6-month mortality in 
traumatic brain injury patients from socio-demographic, computed tomography, and 
laboratory data (van der Ploeg et al., 2016). Similarly, logistic regression outperformed 
random forest and support vector machines, when predicting treatment resistance in 
major depressive disorder (Perlis, 2013). Of course, this does not mean that machine 
learning methods would also perform worse in every prediction of psychosis scenario (for 
example, they might still be superior when predicting psychosis from neuroimaging data). 
However, based on the above findings, it seems rather unlikely that they would be vastly 
superior in most scenarios. Second, machine learning methods are less interpretable 
and more difficult to communicate to clinicians (Steyerberg et al., 2014). For example, 
regression models can transparently be presented, with insight in relative effects of 
predictors by odds or hazard ratios, while many machine learning models are essentially 
black boxes with highly complex prediction equations.  Third, while traditional methods 
can be easily adjusted to local settings (e.g. by changing the model intercept), this is 
more difficult for machine learning methods (Steyerberg et al., 2014). However, the 
ability to adjust the model, also called re-calibration (Steyerberg, 2009), is important in 
prediction of psychosis, as rates of transition to psychosis have been shown to vary 
considerably across time and location (Fusar-Poli et al., 2012). 
With regard to variable selection strategies, we found that univariable screening of 
candidate predictors and/or stepwise variable selection were frequently conducted in 
both predictor finding and model development studies. However, these methods have 
long been criticized on multiple grounds (Harrell, 2001, Nunez et al., 2011, Steyerberg, 
2009). Specifically, when the EPV ratio is low, the variable selection is unstable, the size 
and significance of the estimated regression coefﬁcients are systematically 
overestimated, and the performance of the selected model is overoptimistic (Derksen 
and Keselman, 1992, Steyerberg et al., 1999, Steyerberg and Vergouwe, 2014, Sun et 
al., 1996). Since the bias introduced by these methods is more severe when EPV ratios 
are low, their use in prediction of psychosis research is particularly problematic. 
Unfortunately, we also found that most studies relied on high significance thresholds, 
such as p < 0.05, for variable selection, which leads to more bias and worse cross-
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validated predictive performance than higher thresholds, particularly in small data sets 
(Steyerberg et al., 1999, Steyerberg et al., 2001). Furthermore, we found that several 
studies performed forward stepwise instead of the more recommended backward 
stepwise selection (Nunez et al., 2011, Steyerberg, 2009). Given that sample sizes in the 
field of early psychosis research are small, a more sensible approach for variable 
selection would be to rely more on external knowledge. For example, candidate 
predictors could be pre-selected by performing meta-analyses or based on theory. If 
external knowledge is not available, a more stable set of predictor variables and reduced 
overfitting can be achieved by applying shrinkage methods (Nunez et al., 2011, 
Steyerberg et al., 2001), such as the LASSO (Tibshirani, 1997), which have only been 
used in two (Chan et al., 2015, Ramyead et al., 2015) of the included studies. 
We also found several studies that categorized or even dichotomized continuous 
predictor variables, which has been strongly discouraged by methodologists because it 
leads to a considerable loss of information, reduced statistical power, residual 
confounding, and decreased predictive accuracy (Altman et al., 2012, Collins et al., 
2016, Royston et al., 2006). Furthermore, many of these studies chose cut-points by 
taking the value that produced the lowest p or highest AUC value, which can lead to a 
serious inflation of the type I error and to an overestimation of the prognostic effect 
(Altman et al., 2012, Hollander et al., 2004). 
Another area that needs considerable improvement concerns model performance 
assessment and evaluation, although this is clearly more important for model 
development and less so for predictor finding studies. We found that none of the 
proposed models has been externally validated and internal cross-validation was carried 
out in only 57% of model development studies and 12% of predictor finding studies. 
Furthermore, half of these used poor internal cross-validation strategies, such as split-
sampling, which wastes half of the data and leads to highly uncertain estimates of model 
performance (Austin and Steyerberg, 2014, Moons et al., 2015), or cross-validating only 
the final model after having conducted data-driven variable selection in the whole 
sample, which leads to highly overoptimistic performance estimates (Krstajic et al., 
2014).  
Since internal cross-validation was conducted infrequently, most studies only reported 
the so called “apparent” performance, which tends to be strongly overoptimistic because 
it is calculated in the same data as used for model building (Moons et al., 2015). 
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Furthermore, most studies did not report the whole spectrum of recommended 
performance measures. For example, calibration, which is a key aspect of the model 
performance (Moons et al., 2015), was rarely assessed and mostly using the Hosmer-
Lemeshow statistic instead of the more recommended calibration-in-the-large and 
calibration slope (Collins et al., 2015, Steyerberg et al., 2010). Moreover, many studies 
reporting classification measures (i.e. sensitivity and specificity) had searched for optimal 
probability thresholds for classification in the same sample as they used for testing, 
which again likely contributed to overoptimism (Leeflang et al., 2008). 
We also found major deficiencies in the way models were presented. Most importantly, 
most studies did not provide enough details to exactly apply the model in a new data set, 
which might at least partially explain why none of these models has yet been externally 
validated. Furthermore, several studies only provided enough details to apply a simplified 
scoring rule but not the original model. However, as explained above, the perceived 
advantage of simplification/categorization comes at high costs. A much better way of 
facilitating the clinical application would be the creation of an online risk calculator 
(Steyerberg and Vergouwe, 2014). This would also allow the clinical use and external 
validation of more complex models (e.g. machine learning algorithms) that cannot be 
described with a simple model formula (Steyerberg et al., 2014). 
Limitations 
Our literature search was restricted to English language journal articles only. Thus, it is 
possible that some relevant literature has been missed. A further limitation is that 
choosing an appropriate modelling strategy is complex and depends on many different 
factors, including research question, study design, sample size and number of variables. 
Although we grouped studies by their aim and relied on guidelines (i.e. the CHARMS) for 
critically appraising the methodology and reporting of the included studies as much as 
possible, some studies might have been treated unfairly due to not taking all specific 
factors into account.  
 
Conclusion 
Taken together, we found that most studies developing a model for predicting the 
transition to psychosis in CHR patients were poorly conducted and reported. Biased and 
inefficient methods, such as complete case analysis, modelling a time-to-event outcome 
as a binary outcome, data-driven univariable and stepwise selection of candidate 
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variables, categorization of continuous predictors, and assessing only the apparent 
predictive performance, were widespread and often applied together and in data sets 
with small EPV ratios, which likely potentiated their harmful consequences. 
Consequently, most published predictive performance estimates in this field are likely 
considerably overoptimistic. Unfortunately, this was rarely acknowledged, since proper 
internal validation was infrequent and external validation not attempted. An essential 
requirement for future studies is therefore to improve model validation. While we 
acknowledge that – due to differences in measurement methods across centers – 
external validation is often difficult, internal validation can and should always be 
performed (Moons et al., 2012). To further enhance progress, future studies should more 
strictly adhere to current checklists and guidelines on clinical prediction models, such as 
the recently published TRIPOD statement (Collins et al., 2015, Moons et al., 2015). 
Since EPV ratios in prediction of psychosis research are small compared to other fields 
of prediction research, researchers in this field should take extra care to not waste 
valuable information and to avoid overfitting, for example, by more strongly relying on 
external information and applying models that are not too adaptive. In Table 3, we have 
summarized our recommendations for improved methodology and reporting in prediction 
of psychosis studies. 
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